Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

November 2024; Volume 44,Issue 11

Reviews

  • Open Access
    Immunoliposomes for Neuroblastoma: Review of the Past Experience and Design of a Novel Nanoparticle
    WILLIAM S. PANOSYAN and DANIEL E. PANOSYAN
    Anticancer Research November 2024, 44 (11) 4665-4675; DOI: https://doi.org/10.21873/anticanres.17294
  • Open Access
    Understanding the Genomic Landscape of Glioblastoma: Opportunities for Targeted Therapies
    SABRINA L. ZELLER, ERIS SPIROLLARI, ANISHA M. CHANDY, SIMON J. HANFT, CHIRAG D. GANDHI and MEENA JHANWAR-UNIYAL
    Anticancer Research November 2024, 44 (11) 4677-4690; DOI: https://doi.org/10.21873/anticanres.17295
  • Open Access
    Potential Transcriptomic Biomarkers for Predicting Platinum-based Chemotherapy Resistance in Patients With High-grade Serous Ovarian Cancer
    SARA COCCHI, JOANNA LOPACINSKA-JØRGENSEN and ESTRID V. HØGDALL
    Anticancer Research November 2024, 44 (11) 4691-4707; DOI: https://doi.org/10.21873/anticanres.17296

Experimental Studies

  • Open Access
    Genome-wide microRNA Analysis Identified miR-210-3p Over-expression in Pancreatic Cancer Tissues as a Predictor of their Local Invasiveness
    TOMOHISA OTSU, MASAMICHI HAYASHI, KEIZO FUJITA, DAIGO KOBAYASHI, NOBUHIKO NAKAGAWA, KEISUKE KURIMOTO, HIDEKI TAKAMI, KOKI NAKANISHI, SHINICHI UMEDA, DAI SHIMIZU, NORIFUMI HATTORI, MITSURO KANDA, CHIE TANAKA, GORO NAKAYAMA and YASUHIRO KODERA
    Anticancer Research November 2024, 44 (11) 4709-4721; DOI: https://doi.org/10.21873/anticanres.17297
  • Open Access
    Investigation of the Efficacy of Nowarta110 in the Treatment of HPV-16 and HPV-18 Oncogenically-transformed Human Cells and Cancer-implanted Animal Models
    JON SIN, MATEI KIOSEA, KHOSROW MAHDAVI, FERRE AKBARPOUR, JOLIE NGUYEN, BO HAN and BA X. HOANG
    Anticancer Research November 2024, 44 (11) 4723-4728; DOI: https://doi.org/10.21873/anticanres.17298
  • Open Access
    Metabolomic Profiling of Large Extracellular Vesicles in Patients Suffering from Small Cell Lung Cancer
    SAID NASER, MATTHIAS SCHULZ, SVEN SCHUCHARDT, ALEXANDER VON HAMMERSTEIN-EQUORD and JUDITH BÜNTZEL
    Anticancer Research November 2024, 44 (11) 4729-4735; DOI: https://doi.org/10.21873/anticanres.17299
  • Open Access
    Lymphocyte Antigen 6 Family Member D (LY6D) Affects Stem Cell Phenotype and Progression of Pancreatic Adenocarcinoma
    SHUMPEI OKIMURA, NAOHIRO NISHIDA, HIDEKAZU TAKAHASHI, YUHKI YOKOYAMA, HIROYUKI YAMAMOTO, ATSUSHI HAMABE, TAKAYUKI OGINO, NORIKATSU MIYOSHI, HIDENORI TAKAHASHI, MAMORU UEMURA, SHOGO KOBAYASHI, MASAKI MORI, YUICHIRO DOKI, HIDETOSHI EGUCHI and HIROFUMI YAMAMOTO
    Anticancer Research November 2024, 44 (11) 4737-4749; DOI: https://doi.org/10.21873/anticanres.17300
  • Open Access
    Differential Effects of Punicic Acid on Cytotoxicity and Peroxiredoxin Expression in MCF-7 Breast Cancer and MCF-10A Normal Cells
    BRADEN QUITMEYER, CHIEMELIE EMELIFE, HANNAH KLAUSNER, OLUWAFEMI GBAYISOMORE and SHELLEY PHELAN
    Anticancer Research November 2024, 44 (11) 4751-4759; DOI: https://doi.org/10.21873/anticanres.17301
  • Open Access
    Fenbendazole and Diisopropylamine Dichloroacetate Exert Synergistic Anti-cancer Effects by Inducing Apoptosis and Arresting the Cell Cycle in A549 Lung Cancer Cells
    THAI Q. NGUYEN, DANG H. NGUYEN, UYEN T. T. PHAN, PHUONG T. T. TRAN, HUONG T. LE, SON H. NGUYEN, JOLIE NGUYEN, BO HAN and BA X. HOANG
    Anticancer Research November 2024, 44 (11) 4761-4772; DOI: https://doi.org/10.21873/anticanres.17302
  • Open Access
    Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells
    SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG M. KANG, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research November 2024, 44 (11) 4773-4778; DOI: https://doi.org/10.21873/anticanres.17303
  • Open Access
    A Gene Expression Signature that Predicts Gastric Cancer Sensitivity to PARP Inhibitor Therapy
    KEIICHI FUJIYA, MASAKUNI SERIZAWA, KEIICHI OHSHIMA, RINA UMEHARA, YUKO WATANABE, TAKESHI NAGASHIMA, ETSURO BANDO, KENICHI URAKAMI, YASUTO AKIYAMA, YASUHIRO TSUBOSA, TAKASHI SUGINO, KEN YAMAGUCHI and MASANORI TERASHIMA
    Anticancer Research November 2024, 44 (11) 4779-4788; DOI: https://doi.org/10.21873/anticanres.17304
  • Open Access
    Compound #41 Targets Acute Myelogenous Leukemia by Inhibiting the Wnt/β-catenin Signaling Pathway
    YUKI HADATE, YASUNAO HATTORI, YUKI TODA, SHIGEKUNI HOSOGI, SEIJI OKADA, YOSHIHIRO HAYASHI and EISHI ASHIHARA
    Anticancer Research November 2024, 44 (11) 4789-4799; DOI: https://doi.org/10.21873/anticanres.17305
  • You have access
    Cytotoxic and Radiosensitizing Effects of European and African Propolis in 3D Lung Carcinoma Cell Cultures
    ANNE VEHLOW, INGA LANGE, SIMON LAGIES, BERND KAMMERER, MANUEL PFEIFER and NILS CORDES
    Anticancer Research November 2024, 44 (11) 4801-4811; DOI: https://doi.org/10.21873/anticanres.17306
  • You have access
    Long Non-coding RNA TPRG1-AS1 Interacts With CLTC in Liver Cancer Cells
    SUNG UNG MOON, MASAUD SHAH, TRINH THANH THAO and HYUN GOO WOO
    Anticancer Research November 2024, 44 (11) 4813-4824; DOI: https://doi.org/10.21873/anticanres.17307
  • Open Access
    Impacts of Matrix Metalloproteinase-11 Genotypes on Pterygium Risk
    NING-YI HSIA, HUNG-CHIH CHEN, HUNG-WEN TSAI, TE-CHUN HSIA, PEI-SHIN HU, YUN-CHI WANG, HOU-YU SHIH, WEN-SHIN CHANG, DA-CHUAN CHENG, DA-TIAN BAU and CHIA-WEN TSAI
    Anticancer Research November 2024, 44 (11) 4825-4831; DOI: https://doi.org/10.21873/anticanres.17308
  • Open Access
    Contributions of Tissue Inhibitor of Metalloproteinase-1 Genotypes to the Risk of Metastasis in Gastric Cancer
    CHUN-KAI FU, HSU-TUNG LEE, JAW-CHYUN CHEN, MEI-DUE YANG, HSU-CHEN CHENG, MEI-CHIN MONG, CHIA-WEN TSAI, WEN-SHIN CHANG, YI-CHIH HUNG and DA-TIAN BAU
    Anticancer Research November 2024, 44 (11) 4833-4841; DOI: https://doi.org/10.21873/anticanres.17309
  • Open Access
    Interplay Between Western Diet and Mammary Cancer: Data from a Chemically-induced Model in Wistar Rats
    JESSICA SILVA, TIAGO AZEVEDO, INÊS AIRES, FRANCISCO PEIXOTO, MARIA J. NEUPARTH, FELISBINA L. QUEIROGA, FERNANDA SEIXAS, RITA FERREIRA, ANA I. FAUSTINO-ROCHA, JOSÉ ALBERTO DUARTE and PAULA A. OLIVEIRA
    Anticancer Research November 2024, 44 (11) 4843-4856; DOI: https://doi.org/10.21873/anticanres.17310
  • Open Access
    PAR1 Is a Candidate Target for the Treatment of Peritoneal Dissemination in Gastric Cancer
    DAISUKE FUJIMOTO and HIROTOSHI KOBAYASHI
    Anticancer Research November 2024, 44 (11) 4857-4867; DOI: https://doi.org/10.21873/anticanres.17311
  • You have access
    Role of Glutamine Synthetase on Vascular Permeability in Gliomas
    DANDAN WANG, TIANWEI SONG, ZONGTAO HU, HONGZHI WANG and JUNCHAO QIAN
    Anticancer Research November 2024, 44 (11) 4869-4875; DOI: https://doi.org/10.21873/anticanres.17312
  • You have access
    Clinical Significance of FAM83G in Breast Cancer: Association With Triple-negative Subtype and Prognosis
    TAKAKO IKEDA, CHIKAKO KANNO HONDA, SASAGU KUROZUMI, TAKEHIKO YOKOBORI, AYAKA KATAYAMA, KEI MASUDA, TETSUNARI OYAMA, KYOICHI KAIRA, JUN HORIGUCHI, KEN SHIRABE and TAKAAKI FUJII
    Anticancer Research November 2024, 44 (11) 4877-4883; DOI: https://doi.org/10.21873/anticanres.17313
  • You have access
    Over-expression of Transmembrane Protein 158 Predicts Aggressive Tumor Behavior and Poor Prognosis in Lung Cancer
    MIYEON JEON, SEONGKYEONG YOO, SOOHYUN PARK, YUNSUP CHOI, JIYEON AN, YOO RIM NOH and ILJIN KIM
    Anticancer Research November 2024, 44 (11) 4885-4893; DOI: https://doi.org/10.21873/anticanres.17314
  • You have access
    Fostamatinib Inhibits the Proliferation of Ovarian Cancer Cells Through Apoptosis Induction
    HYE MIN LEE, HEE JIN CHO, YUL MIN LEE, HYUN JUNG KIM and KYUN HEO
    Anticancer Research November 2024, 44 (11) 4895-4903; DOI: https://doi.org/10.21873/anticanres.17315
  • Open Access
    New Treatment Modalities for Colorectal Cancer Through Simultaneous Suppression of FSP1 and GPX4
    CHIHARU YASUI, YUSUKE KONO, RYO ISHIGURO, TAKUKI YAGYU, KIHARA KYOICHI, MANABU YAMAMOTO, TOMOYUKI MATSUNAGA, SHUICHI TAKANO, NARUO TOKUYASU, TERUHISA SAKAMOTO, TOSHIMICHI HASEGAWA, YOSHIHISA UMEKITA and YOSHIYUKI FUJIWARA
    Anticancer Research November 2024, 44 (11) 4905-4914; DOI: https://doi.org/10.21873/anticanres.17316
  • You have access
    Combined Treatment of Caffeic Acid Phenethyl Ester With Docetaxel Inhibits Survival of Non-small-cell Lung Cancer Cells via Suppression of c-MYC
    LI-KUO KUO, YU-KE FU, CHIEN-CHIH YEH, CHING-YI LEE, CHI-JUNG CHUNG, LI-JANE SHIH, HSIN-YING LU and CHIH-PIN CHUU
    Anticancer Research November 2024, 44 (11) 4915-4928; DOI: https://doi.org/10.21873/anticanres.17317
  • You have access
    CD47 and Calreticulin Expression in Breast Cancer Subtypes and Anti-CD47 Inhibitory Effects in Macrophage-mediated Phagocytosis
    JUTHAMARD CHANTARAAMPORN, PHATTARIN POTHIPAN, TITIPATIMA SAKULTERDKIAT, BURANA KHIANKAEW, LALITA LUMKUL, PHOTSATHORN MUTAPAT, PHICHAMON PHETCHAHWANG, JISNUSON SVASTI and VORARATT CHAMPATTANACHAI
    Anticancer Research November 2024, 44 (11) 4929-4940; DOI: https://doi.org/10.21873/anticanres.17318
  • You have access
    Single-agent Adavosertib Shows Anticancer Effects Against Colorectal Cancer Cells
    MAI LY THI NGUYEN, CHI PHAM, TAI SUC NGUYEN, PHUONG LINH THI NHAM, QUYNH CHI DO, PHUONG LINH TRAN, ANH VU NGUYEN, NHU NGOC NGUYEN, DIEU LINH LE, ANH THO THI TRAN, THI LAP NGUYEN, PRZEMYSLAW BOZKO, LINH TOAN NGUYEN and KHAC CUONG BUI
    Anticancer Research November 2024, 44 (11) 4941-4949; DOI: https://doi.org/10.21873/anticanres.17319

Clinical Studies

  • Open Access
    Biomarker Study for Selecting Neoadjuvant Chemotherapy Regimens Based on Prognostic Prediction Using Gastric Cancer Biopsy Specimens from a Phase II Randomized Controlled Trial
    TAKASHI OSHIMA, TAKAKI YOSHIKAWA, YOHEI MIYAGI, SATOSHI MORITA, MICHIO YAMAMOTO, KAZUAKI TANABE, KAZUHIRO NISHIKAWA, YUICHI ITO, TAKANORI MATSUI, YUTAKA KIMURA, TORU AOYAMA, TAKASHI OGATA, HARUHIKO CHO, AKIRA TSUBURAYA and JUNICHI SAKAMOTO
    Anticancer Research November 2024, 44 (11) 4951-4960; DOI: https://doi.org/10.21873/anticanres.17320
  • Open Access
    Chemokine Profile Is Different in Normal Testis Compared to Seminoma – Especially in Tumor Infiltrating Lymphocytes
    JONAS M. HÄNDELIN, HANNA-RIIKKA TEPPO, KIRSI-MARIA HAAPASAARI, RIINA K. OLLIKAINEN, JANETTE KEMPPAINEN, HANNE KUITUNEN, OUTI KUITTINEN and MILLA E.L. KUUSISTO
    Anticancer Research November 2024, 44 (11) 4961-4967; DOI: https://doi.org/10.21873/anticanres.17321
  • Open Access
    Comprehensive Clinicopathological and Immunohistochemical Analysis of Human Papillomavirus-independent Squamous Cell Carcinoma and Adenosquamous Carcinoma of the Uterine Cervix
    JI MIN NA and HYUN-SOO KIM
    Anticancer Research November 2024, 44 (11) 4969-4981; DOI: https://doi.org/10.21873/anticanres.17322
  • Open Access
    Comparison of the Predictive and Prognostic Capacities of Neutrophil, Lymphocyte and Platelet Counts and Tumor-infiltrating Lymphocytes in Triple-negative Breast Cancer: Preliminary Results of the PERCEPTION Study
    ALEXIA GIRO, JUDITH PASSILDAS-JAHANMOHAN, MYRIAM KOSSAI, YANNICK BIDET, IOANA MOLNAR, MAUREEN BERNADACH, FREDERIQUE PENAULT-LLORCA, CATHERINE ABRIAL, XAVIER DURANDO and NINA RADOSEVIC-ROBIN
    Anticancer Research November 2024, 44 (11) 4983-4994; DOI: https://doi.org/10.21873/anticanres.17323
  • You have access
    Clinical and Oncological Impact of a Protective Ileostomy in Rectal Cancer Patients Undergoing Adjuvant Chemotherapy
    ALIZÉE ZADOROZNYJ, ELIAS KARAM, NICOLAS MICHOT, JULIEN THIERY, THIERY LECOMTE, DRIFFA MOUSSATA, SOPHIE CHAPET, GILLES CALAIS, EPHREM SALAME, URS PABST-GIGER and MEHDI OUAISSI
    Anticancer Research November 2024, 44 (11) 4995-5005; DOI: https://doi.org/10.21873/anticanres.17324
  • Open Access
    Invasive Stratified Mucin-producing Carcinoma of the Uterine Cervix: Comparison of Its Clinicopathological Characteristics and Programmed Death-ligand 1 Expression Status With Those of Other Endocervical Adenocarcinomas
    JIYEON LEE, SANG AH CHI, SANGJOON CHOI and HYUN-SOO KIM
    Anticancer Research November 2024, 44 (11) 5007-5022; DOI: https://doi.org/10.21873/anticanres.17325
  • Open Access
    Association Between ABCC2 −24C>T and Nab-Paclitaxel-induced Peripheral Neuropathy in Japanese Patients With Pancreatic Cancer
    HANA NAKAYAMA, HIROO ISHIDA, MASANORI IIDAKA, SHOKO KATO, KEI NAKATANI, AKIHIRO NAKAYAMA, TOSHIHIRO NOGUCHI, SHIGETOSHI NISHIHARA, SHU OIKAWA, TOMONO USAMI, YUTA MITSUI, YU ISHII, HIROKAZU TOSHIMA, KOUJI KOBAYASHI, REMI MURASE, NATSUMI MATSUMOTO, KOSUKE SUZUKI, KEN SHIMADA, HITOSHI YOSHIDA and KEN-ICHI FUJITA
    Anticancer Research November 2024, 44 (11) 5023-5033; DOI: https://doi.org/10.21873/anticanres.17326
  • Open Access
    The Clinical Impact of the Systemic Immune-inflammation Index in Esophageal Cancer Patients Receiving Curative Treatment
    RYUKI ESASHI, TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, SOSUKE YAMAMOTO, MAMORU UCHIYAMA, KOJI NUMATA, SHINNOSUKE KAWAHARA, KEISUKE KAZAMA, AYAKO TAMAGAWA, AYA SAITO and NORIO YUKAWA
    Anticancer Research November 2024, 44 (11) 5035-5041; DOI: https://doi.org/10.21873/anticanres.17327
  • Open Access
    Preoperative Tumor Growth Rate Does Not Predict Overall or Progression-free Survival in Patients With Glioblastoma
    JAN LEPPERT, CLAUDIA DITZ, JAKOB MATSCHKE, MARIA.VITTORIA MATONE, PATRICK KUPPLER, CHRISTINA HILLBRICHT, HARALD KRENZLIN, NAUREEN KERIC, HANNES SCHACHT, CHRISTIAN ZIEMANN, ELISA MARIA GROH, LARYSA LIUBICH, OKSANA ZEMSKOVA, DIRK RADES and ANASTASSIA LÖSER
    Anticancer Research November 2024, 44 (11) 5043-5049; DOI: https://doi.org/10.21873/anticanres.17328
  • Open Access
    Impact of Pre-operative Lymphocyte and Albumin Combination on Adjuvant Chemotherapy and Prognosis of Gastric Cancer
    TOSHIYA HIGASHI, MASAKI KIMURA, YUKI KATO, KIMIHIRO HATTORI, MANA KAWAJIRI, YUSUKE MURASE, KOYA TOCHII and HIDETOSHI MATSUNAMI
    Anticancer Research November 2024, 44 (11) 5051-5058; DOI: https://doi.org/10.21873/anticanres.17329
  • You have access
    Routine Elastic Staining Helps Detection of Vascular Invasion in Colorectal Cancer: A Comprehensive Analysis of T3 or Higher Tumors Without Lymph Node Metastasis
    YOU-NA SUNG, YESEUL KIM, ANNA THERESE DATUIN, INHO JANG and JONGMIN SIM
    Anticancer Research November 2024, 44 (11) 5059-5065; DOI: https://doi.org/10.21873/anticanres.17330
  • Open Access
    A Prospective Observational Study Analyzing the Diversity and Specific Composition of the Oral and Gut Microbiota in Lung Cancer Patients
    FUMIHIRO SHOJI, AYAKA MINEMURA, YUKA KOZUMA, TAKASHI NOUNO, HIROAKI TAKEOKA, ASAMI MATSUMOTO, MASAKI OKAMOTO, MASAFUMI YAMAGUCHI, KOJI YAMAZAKI and YOSHIHIKO MAEHARA
    Anticancer Research November 2024, 44 (11) 5067-5080; DOI: https://doi.org/10.21873/anticanres.17331
  • You have access
    Accuracy of Preoperative Magnet Resonance Imaging to Predict Pathologic T-Stage in Patients With Cervical Cancer
    CAROLINE LENZ, LARA GESEMANN, YUSSOR AL-BALDAWI, MICHAEL PÜSKEN, AMELIE WINGELS, PETER MALLMANN, CONSTANZE AMIR-KARIBIAN, JANICE K. JESCHKE, JANA ADAMS, BERND MORGENSTERN and FABINSHY THANGARAJAH
    Anticancer Research November 2024, 44 (11) 5081-5085; DOI: https://doi.org/10.21873/anticanres.17332
  • You have access
    Efficacy and Safety of Nivolumab With Ipilimumab in Elderly Patients With Advanced Renal Cell Carcinoma
    KOSUKE UEDA, NAOKI ITO, YUYA SAKAI, SATOSHI OHNISHI, TAISHI HIRANO, HIROFUMI KUROSE, KATSUAKI CHIKUI, KEIICHIRO UEMURA, KIYOAKI NISHIHARA, MAKOTO NAKIRI, SHIGETAKA SUEKANE and TSUKASA IGAWA
    Anticancer Research November 2024, 44 (11) 5087-5093; DOI: https://doi.org/10.21873/anticanres.17333
  • You have access
    Association of Plasma Nestin With Response to Immune Checkpoint Inhibitors Combined With Chemotherapy in Extensive-stage Small-cell Lung Cancer: A Pilot Study
    YUTO SUZUKI, KEN MAENO, YUSUKE KAGAWA, KAZUKI SONE, SATOSHI FUKUDA, TAKEHIRO UEMURA, AYAKO MASAKI, SANAE TODA, YUTA MORI, KENSUKE FUKUMITSU, YOSHIHIRO KANEMITSU, TOMOKO TAJIRI, YUTAKA ITO, TETSUYA OGURI and AKIO NIIMI
    Anticancer Research November 2024, 44 (11) 5095-5104; DOI: https://doi.org/10.21873/anticanres.17334
  • You have access
    Long-term Responders to Nanoparticle Albumin-bound Paclitaxel Following Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer
    KOKI NAKASHIMA, YUKIHIRO UMEDA, YOSHIKI DEMURA, KOJI YAMAOKA, TOMOAKI SONODA, TOSHIHIKO TADA, YUKO WASEDA and TAMOTSU ISHIZUKA
    Anticancer Research November 2024, 44 (11) 5105-5111; DOI: https://doi.org/10.21873/anticanres.17335
  • You have access
    Development of a Tumor Growth-responsive Robust Planning Method for Head and Neck Cancer in Carbon-ion Radiotherapy
    YUYA MIYASAKA, YOHSUKE KUSANO, NOBUTAKA MIZOGUCHI, YOSHIKI TAKAYAMA, TADASHI KAMADA, TAKEO IWAI and HIROYUKI KATOH
    Anticancer Research November 2024, 44 (11) 5113-5122; DOI: https://doi.org/10.21873/anticanres.17336
  • You have access
    Predictive Value of Immune Activity Changes in Breast Cancer Patients Treated With Dose-dense Neoadjuvant Chemotherapy: A Retrospective Study
    WATARU GOTO, SAEKO HENMI, HANAE MATSUDA, KEI NAKATA, YUKO KIKUKAWA, MARIKO NISHIKAWA, ASUKA KOUCHI, RIKA SUGAHARA, KOJI TAKADA, YUKIE TAUCHI, KANA OGISAWA, TAMAMI MORISAKI and SHINICHIRO KASHIWAGI
    Anticancer Research November 2024, 44 (11) 5123-5129; DOI: https://doi.org/10.21873/anticanres.17337
  • You have access
    Nomogram Predicting Axillary Lymph Node Dissection Omission After Neoadjuvant Chemotherapy for Node-positive Breast Cancer
    HIROHITO SEKI, YUKI ISHIGURO, AKITSUGU MAKINO, KEI YAMAGUCHI and SHIGERU IMOTO
    Anticancer Research November 2024, 44 (11) 5131-5138; DOI: https://doi.org/10.21873/anticanres.17338
  • You have access
    Packing of the Gastroduodenal Artery Stump Using Falciform Ligament During Pancreaticoduodenectomy
    TERUYUKI USUBA, RYOTA IWASE, YUICHI NAKASEKO, SHINJI ONDA, YOSHIHIRO SHIRAI, MASASHI TSUNEMATSU, MASAICHI OGAWA and TORU IKEGAMI
    Anticancer Research November 2024, 44 (11) 5139-5145; DOI: https://doi.org/10.21873/anticanres.17339
  • You have access
    Identification of Plasma Protein Biomarkers for Predicting Lung Cancer
    KI SA SUNG, SANG JUN HAN, JIHYE LEE, MINSEOK KWON, DUK-HWAN KIM and YOUNG SUN OH
    Anticancer Research November 2024, 44 (11) 5147-5155; DOI: https://doi.org/10.21873/anticanres.17340
Back to top
PreviousNext

In this issue

Anticancer Research: 44 (11)
Anticancer Research
Vol. 44, Issue 11
November 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Immunoliposomes for Neuroblastoma: Review of the Past Experience and Design of a Novel Nanoparticle
  • Potential Transcriptomic Biomarkers for Predicting Platinum-based Chemotherapy Resistance in Patients With High-grade Serous Ovarian Cancer
  • Biomarker Study for Selecting Neoadjuvant Chemotherapy Regimens Based on Prognostic Prediction Using Gastric Cancer Biopsy Specimens from a Phase II Randomized Controlled Trial
  • Understanding the Genomic Landscape of Glioblastoma: Opportunities for Targeted Therapies
  • Chemokine Profile Is Different in Normal Testis Compared to Seminoma – Especially in Tumor Infiltrating Lymphocytes
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire